Actividad Investigadora
Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases
Datos básicos
- Código:
- EU13/01- PRECISESADS
- Dotación:
- 127.950,00 €
- Año Inicial:
- 2014
- Año final:
- 2019
Objetivos del proyecto
The PRECISESADs consortium concurs to this call as a translational network of outstanding clinical, translational and basic researchers and practicing physicians with the common aim to give this challenge a practical and clinically relevant answer.The PRECISESADS project studied over 2 000 people with various autoimmune diseases, gathering data on the molecular causes of their disease as well as their clinical symptoms. Using this information, they will identified potential new classifications of these diseases, something that could allow doctors to offer patients more personalised treatments at an earlier stage of their disease.
Unidades de investigación
Documentos
- No hay documentos
Participantes
Financiadores
